Ghent University Academic Bibliography

Journal Article
A1
open access

Impact of pneumatic tube transportation on the aggregation of monoclonal antibodies in clinical practice

Michaela Cohrs (UGent) , Nele Clottens (UGent) , Pieter Ramaut (UGent) , Kevin Braeckmans (UGent) , Stefaan De Smedt (UGent) , Tieneke Bauters (UGent) and Hristo Svilenov (UGent)

(2025) EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 204.

Add to list

Journal Article
A1
open access

Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study

Isabel Leroux-Roels (UGent) , Azhar Alhatemi (UGent) , Magalie Caubet, Fien De Boever (UGent) , Bertrand de Wergifosse, Mohamed El Idrissi, Guilherme S Ferreira, Bart Jacobs (UGent) , Axel Lambert, Sandra Morel, et al.

(2025) JOURNAL OF INFECTIOUS DISEASES. 231(3). p.e511-e520

Add to list

Journal Article
A1
open access

AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells

Valentino D'Onofrio (UGent) , Ana Carolina Santana, Marthe Pauwels, Gwenn Waerlop (UGent) , Anthony Willems (UGent) , Fien De Boever (UGent) , Martin Müller, Peter Sehr, Tim Waterboer, Isabel Leroux-Roels (UGent) , et al.

(2025) FRONTIERS IN IMMUNOLOGY. 16.

Add to list

Journal Article
A1
open access

Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics

Michaela Cohrs (UGent) , Paula E. Borgonje, Nele Clottens (UGent) , Pieter Ramaut (UGent) , Kevin Braeckmans (UGent) , Stefaan De Smedt (UGent) , Hristo Svilenov (UGent) and Tieneke Bauters (UGent)

(2025) JOURNAL OF ONCOLOGY PHARMACY PRACTICE.

Add to list

Challenges and opportunities in mRNA vaccine development against bacteria

Ilke Aernout (UGent) , Rein Verbeke (UGent) , Fabien Henri Thery (UGent) , Patrick Willems (UGent) , Uri Elia, Stefaan De Smedt (UGent) , Rino Rappuoli, Dan Peer, Francis Impens (UGent) and Ine Lentacker (UGent)

(2025) NATURE MICROBIOLOGY. 10(8). p.1816-1828

Add to list

Journal Article
A1
open access

Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo

Irene Garcia-Fogeda, Steven Abrams, Stijn Vanhee (UGent) , Maha Salloum, Benson Ogunjimi and Niel Hens

(2025) VACCINE. 64.

Add to list

Journal Article
A1
open access

Accelerating neoantigen discovery : a high-throughput approach to immunogenic target identification

Lena Pfitzer, Gitta Boons, Lien Lybaert, Wim Van Criekinge (UGent) , Cedric Bogaert and Bruno Fant

(2025) VACCINES. 13(8).

Add to list

Journal Article
A1
open access

Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults : randomized, phase 1/2 study

Isabel Leroux-Roels (UGent) , Cathy Maes, Francesca Mancini, Bart Jacobs (UGent) , Eleanna Sarakinou, Azhar Alhatemi (UGent) , Jasper Joye, Silvia Grappi, Giulia Luna Cilio, Alimamy Serry-Bangura, et al.

(2024) JOURNAL OF INFECTIOUS DISEASES. 230(4). p.e971-e984

Add to list

Journal Article
A1
open access

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons

Michael G Ison, Alberto Papi, Eugene Athan, Robert G Feldman, Joanne M Langley, Dong-Gun Lee, Isabel Leroux-Roels (UGent) , Federico Martinon-Torres, Tino F Schwarz, Richard N van Zyl-Smit, et al.

(2024) CLINICAL INFECTIOUS DISEASES. 78(6). p.1732-1744

Add to list

Journal Article
A1
open access

Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Bart Jacobs, Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Azhar Alhatemi (UGent) , Philippe Moris, et al.

(2024) VACCINES. 12(12).

Academic Bibliography

Impact of pneumatic tube transportation on the aggregation of monoclonal antibodies in clinical practice

Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study

AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells

Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics

Challenges and opportunities in mRNA vaccine development against bacteria

Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo

Accelerating neoantigen discovery : a high-throughput approach to immunogenic target identification

Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults : randomized, phase 1/2 study

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons

Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Contents

Support

Contact